Novartis' Afinito Significantly Improves Progression-Free Survival In Advanced Nonfunctional GI and Lung NET
September 27, 2015 at 06:48 AM EDT
Novartis (NYSE: NVS) announced Saturday, results of a Phase III pivotal study showing Afinitor® (everolimus) tablets reduced the risk of ...